X4 Pharmaceuticals, Inc Annual Share-based Payment Arrangement, Expense in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
X4 Pharmaceuticals, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2023.
  • X4 Pharmaceuticals, Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.82M, a 22.9% decline year-over-year.
  • X4 Pharmaceuticals, Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $8.53M, a 17.5% increase year-over-year.
  • X4 Pharmaceuticals, Inc annual Share-based Payment Arrangement, Expense for 2023 was $8.69M, a 67.1% increase from 2022.
  • X4 Pharmaceuticals, Inc annual Share-based Payment Arrangement, Expense for 2022 was $5.2M, a 15.9% decline from 2021.
  • X4 Pharmaceuticals, Inc annual Share-based Payment Arrangement, Expense for 2021 was $6.18M, a 13.9% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $8.69M +$3.49M +67.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $5.2M -$981K -15.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $6.18M +$752K +13.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-21
2020 $5.43M +$3.38M +165% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-21
2019 $2.05M +$1.29M +170% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-17
2018 $759K +$267K +54.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-19
2017 $492K -$152K -23.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $644K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.